Publications
Preprint · arXiv 2607.12117

Mpro-DockExec: an executability benchmark for SARS-CoV-2 docking claims

NewScience ResearchbioRxiv · 2026

A source-verified, agent-assisted audit of SARS-CoV-2 main-protease (Mpro) molecular docking — the first protocol of the reproduce engine, run by hand.

We gathered 236 open-access docking papers — around 12,466 individual ligand results — and audited every one against a sixteen-field reporting standard built for the job. The picture was bleak: only 8.1% of papers reported enough to run their docking from the methods alone, nearly half were blocked outright by a single missing parameter, and not one of the 236 was fully reproducible.

236
Confirmed Mpro docking papers audited — roughly 12,466 ligand-level claims.
8.1%
Of papers are directly re-executable. 47.9% are blocked by a single missing parameter.
0.36
kcal/mol median agreement on re-docked claims, with 81% within 2 kcal/mol.
κ 0.926
Agreement between two independent reviewers — versus κ 0.075 for an AI-only holistic pass.

Executability class predicts reproducibility: cleanly-reported papers re-docked within a median 0.36 kcal/mol of the published number, while execution-blocked papers couldn’t be reconstructed at all. And the grading itself only holds up when it’s rule-based — a holistic AI-only pass agreed with expert reviewers barely better than chance, while a deterministic classifier reading the same pinned parameters matched two independent experts almost exactly.

Release — Mpro-DockExec: an open, corpus-scale executability benchmark, scoring engine, re-execution scripts, and provenance package.

Read the full preprint

Available now on arXiv.

Read on arXiv